Drug therapy for anxiety in adult palliative care patients

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Jackson, Kenneth C ^a   Lipman, Arthur G ^b  

^a PACIFIC UNIVERSITY   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Anti anxiety agents *therapeutic use ; Anxiety *drug therapy ; Humans; Palliative care; Terminally ill *psychology

Indexed keywords

CHLORPROMAZINE; HALOPERIDOL; LORAZEPAM;

ADULT DISEASE; AIDS PATIENT; CLINICAL TRIAL; COGNITIVE DEFECT; DELIRIUM; DRUG WITHDRAWAL; DYSKINESIA; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; HUMAN; REVIEW; SEDATION; SIDE EFFECT; TERMINALLY ILL PATIENT;

EID: 77950134235     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004596     Document Type: Review

References (17)

1. Barreto 1996 {published data only} Barreto P, Bayes R, Comas MD, Martinez E, Pascual A, Roca J, et al.Assessment of the perception of symptoms and anxiety in terminally ill patients in Spain. Journal of Palliative Care 1996;12(2):43-6.
2. Bruera 1986 {published data only} Bruera E, Carraro S, Roca E, Barugel M, Chacon R. Double-blind evaluation of the effects of mazindol on pain, depression, anxiety, appetite, and activity in terminal cancer patients. Cancer Treatment Reports 1986;70(2):295-8.
3. Butters 1992 {published data only} Butters E, Higginson I, George R, Smits A, McCarthy M. Assessing the symptoms, anxiety and practical needs of HIV/AIDS patients receiving palliative care. Quality of Life Research 1992;1:47-51.
4. Fernandez 1987 {published data only} Fernandez F, Adams F, Holmes VF. Analgesic effect of alprazolam in patients with chronic, organic pain of malignant origin. Journal of Clinical Psychopharmacology 1987;7(3):167-9.
5. Holland 1991 {published data only} Holland JC, Morrow GR, Schmale A, Dragatis, L, Stefanek M, Berenson S, et al.A randomized clinical trial of alprazolam verus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms. Journal of Clinical Oncology 1991;9(6):1004-11.
6. Wald 1993 {published data only} Walt TG, Kathol RG, Noyes Jr. R, Carroll BT, Clamon GH. Rapid relief of anxiety in cancer patients with both alprazolam and placebo. Psychosomatics 1993;34(4):324-32.
7. APA 1995 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4. Arlington, VA: American Psychiatric Publishing Inc, 1995.
8. Breitbart 1996 Breitbart W, Jacobsen PB. Psychiatric symptom management in terminal care. Clin Geriatr Med 1996;12:329-47.
9. Jackson 1999 Jackson KC, Lipman AG. Anxiety in palliative care patients. Journal of Pharmaceutical Care in Pain and Symptom Control 1999;7(4):23-35.
10. Jadad 1996 Jadad AR, Moore RA, Carroll D, et al.Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17(1):1-12.
11. Khojainova 2002 Khojainova N, Santiago-Palma J, Kornick C, Breitbart W, Gonzales GR. Olanzapine in the management of cancer pain. Journal of Pain and Symptom Management 2002;23(4):346-50.
12. Maguire 1993 Maguire P, Faulkner A, Regnard C. Managing the anxious patient with advancing disease - a flow diagram. Palliative Medicine 1993;7:239-44.
13. Mintzer 2001 Mintzer J, Faison W, Street JS, Sutton VK, Breier A. Olanzapine in the treatment of anxiety symptoms due to Alzheimer's disease: a post hoc analysis. International Journal of Geriatric Psychiatry 2001;16(supplement 1):S71-S77.
14. Noyes 1998 Noyes R, Holt CS, Massie MJ. Anxiety disorders. In: Holland JC editor(s). Psycho-oncology. New York: Oxford University Press, 1998:548-63.
15. Roth 1996 Roth AJ, Breitbart W. Psychiatric emergencies in terminally ill cancer patients. Pain and Palliative Care 1996;10:235-59.
16. Shapiro 1995 Shapiro B, Warren J, Egol AB. practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Critical Care Medicine 1995;23(9): 1596-600.
17. Stiefel 1994 Stiefel F, Razai D. Common psychiatric disorders in cancer patients: II. Anxiety and acute confusional states. Supportive Care in Cancer 1994;2:233-7.